BioCentury This Week

BioCentury This Week

BioCentury

382 - Ep. 372 - Biotech IPOs, Biosecure Act, cachexia pipeline

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.

For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

382 - Ep. 372 - Biotech IPOs, Biosecure Act, cachexia pipeline
00:00
00:00

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.

For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

에피소드

382-

Ep. 372 - Biotech IPOs, Biosecure Act, cachexia pipeline

월, 15 6월 2026
381-

Ep. 371 - Moving faster at the academia-industry interface

수, 10 6월 2026
380-

Ep. 370 - Calmer waters for FDA; Servier, Lilly deals

월, 08 6월 2026
379-

Ep. 369 - ASCO advances, China innovation & U.S. science under threat

월, 01 6월 2026
378-

Ep. 368 - ASCO Preview, China Policy, ADC Linkers

화, 26 5월 2026